C3501592||Cl-NQTrp
C0949664||Tauopathy
C1457887||Symptoms
C0012644||Model Organism
C0085401||Tau
C3850147||Aggregation
C0600688||Toxicity
C0002395||Alzheimer's disease
C0002395||Alzheimer's disease
C0949664||tauopathy
C0333463||plaques
C0085401||tau
C0085400||tangles
C1655065||unfolding
C0599220||monomeric subunits
C0162806||Î²-sheet
C0225328||fibrils
C0184661||Intervening
C3850147||aggregation
C0087111||therapeutic approach
C0012634||disease
C0087111||therapy
C0002395||Alzheimer's disease
C0949664||tauopathies
C3711678||naphthoquinone-tryptophan hybrid
C3711678||NQTrp
C0949664||tauopathy
C1515655||in vivo
C3711678||NQTrp
C0443343||not very stable
C3711678||NQTrp
C0596019||Cl ion
C3501592||Cl-NQTrp
C0085401||tau
C3850147||aggregation
C1515655||in vivo
C3501592||Cl-NQTrp
C3850147||aggregation
C1456454||amyloidogenic proteins
C0030956||peptides
C3501592||Cl-NQTrp
C1335533||PHF6
C3850147||aggregation
C1335533||fragment
C0085401||tau
C0949664||tauopathy
C1457887||symptoms
C0003069||transgenic
C0013138||Drosophila
C1519606||model
C0085401||tau
C3850147||aggregation
C0600688||toxicity
C3501592||Cl-NQTrp
C0002395||Alzheimer's disease
C3850147||aggregation
C0085401||tau